My reaction today exactly. As surely many others. Certainly on this board, and soon in the wider investment and Pharma community.
TOB, I last ran into the now "senior advisor" of Cubist six years ago at Whistling Straits and it was very cordial. It's sweet to know that we just beat their lead drug by a mile. The fact that they're a 5.3B company makes my heart go thump, thump, thump. Oh boy!!!! -58nout
Soon after the news hit I visited the Cubist website for the first time, looked at their market cap, treatments and pipeline.
Cellceutix went from a newbie to a serious contender for the heavyweight title today.